Cargando…

Levels of Soluble CD30 and CD26 and Their Clinical Significance in Patients with Primary Immune Thrombocytopenia

BACKGROUND: sCD30 and sCD26 are correlated with autoimmune diseases. However, little research has been done on the relationship between them and primary immune thrombocytopenia (ITP). METHODS: This study enrolled 47 patients diagnosed with ITP in the Institute of Hematology and Blood Disease Hospita...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Honghui, Gu, Xueping, Li, Huiyuan, Yin, Lingmei, Tao, Wei, Yu, Jingxing, Zhou, Qiyuan, Mu, Hongli, Shen, Yu, Yao, Jin, Liu, Lin, Bi, Hui, Yang, Renchi, Zhou, Zeping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152940/ https://www.ncbi.nlm.nih.gov/pubmed/32337220 http://dx.doi.org/10.1155/2020/1279371

Ejemplares similares

Clinical Significance of Soluble CD26 in Malignant Pleural Mesothelioma
por: Fujimoto, Nobukazu, et al.
Publicado: (2014)

Skin CD30(+) T cells and circulating levels of soluble CD30 are increased in patients with graft versus host disease
por: Amedei, Amedeo, et al.
Publicado: (2013)

Prognostic Significance of CD26 in Patients with Colorectal Cancer
por: Lam, Colin Siu-Chi, et al.
Publicado: (2014)

High soluble CD30, CD25 and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides
por: Kadin, Marshall E., et al.
Publicado: (2011)

Prognostic significance of CD30 expression in nasal natural killer/T-cell lymphoma
por: Wang, Guan-Nan, et al.
Publicado: (2017)

Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
por: Feng, Lin, et al.
Publicado: (2012)

Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody
por: Kaneko, Yutaro, et al.
Publicado: (2021)

Soluble CD26 is inversely Associated with Disease Severity in Patients with Chronic Eosinophilic Pneumonia
por: Matsuno, Osamu, et al.
Publicado: (2007)

Soluble CD26 Levels and Its Association to Epidemiologic Parameters in a Sample Population
por: De Chiara, Loretta, et al.
Publicado: (2009)

CD26 and Cancer
por: Cordero, Oscar J.
Publicado: (2022)

Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30
por: Pelser, Colleen, et al.
Publicado: (2010)

Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway
por: Crow, Andrew R., et al.
Publicado: (2013)

Evaluation of Soluble CD90: Potential for Diagnostic Significance in Endometriosis Patients
por: Bochev, Ivan M., et al.
Publicado: (2022)

Increased Expression of Ganglioside GM1 in Peripheral CD4+ T Cells Correlates Soluble Form of CD30 in Systemic Lupus Erythematosus Patients
por: Dong, Lingli, et al.
Publicado: (2010)

Serum Levels of Soluble CD26, A Novel Prognostic Marker for Hepatitis E Infection
por: Rafiei, Alireza, et al.
Publicado: (2016)

Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs
por: De Chiara, Loretta, et al.
Publicado: (2022)

Adult T-cell leukemia/lymphoma following elevation of serum levels of soluble cytokine receptors, sCD25 and sCD30
por: Takemoto, Shigeki, et al.
Publicado: (2014)

The influence of CD26(+) and CD26(−) fibroblasts on the regeneration of human dermo-epidermal skin substitutes
por: Michalak-Micka, Katarzyna, et al.
Publicado: (2022)

Distinctive CD26 Expression on CD4 T-Cell Subsets
por: Cordero, Oscar J., et al.
Publicado: (2021)

Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30(+) lymphoma patients
por: Wang, D., et al.
Publicado: (2020)

Elevated Serum Levels of Soluble CD30 in Ankylosing Spondylitis Patients and Its Association with Disease Severity-Related Parameters
por: Gao, Rongfen, et al.
Publicado: (2015)

Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30(+) lymphoma
por: Zhang, Peiling, et al.
Publicado: (2022)

CD9 Negatively Regulates CD26 Expression and Inhibits CD26-Mediated Enhancement of Invasive Potential of Malignant Mesothelioma Cells
por: Okamoto, Toshihiro, et al.
Publicado: (2014)

CD30-Positive Extracellular Vesicles Enable the Targeting of CD30-Negative DLBCL Cells by the CD30 Antibody-Drug Conjugate Brentuximab Vedotin
por: Lobastova, Liudmila, et al.
Publicado: (2021)

CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis
por: Cordero, Oscar J., et al.
Publicado: (2015)

CD26-Related Serum Biomarkers: sCD26 Protein, DPP4 Activity, and Anti-CD26 Isotype Levels in a Colorectal Cancer-Screening Context
por: De Chiara, Loretta, et al.
Publicado: (2020)

Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma
por: Etzerodt, Anders, et al.
Publicado: (2017)

The role of CD8(+) T-cell clones in immune thrombocytopenia
por: Malik, Amna, et al.
Publicado: (2023)

Correction: CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis
por: Cordero, Oscar J., et al.
Publicado: (2015)

CD8(+) T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia
por: Qiu, Jihua, et al.
Publicado: (2016)

Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication
por: Huo, Yu-Jia, et al.
Publicado: (2022)

Soluble CD93 in allergic asthma
por: Park, Hye Jung, et al.
Publicado: (2020)

Cytomembrane Trafficking Pathways of Connexin 26, 30, and 43
por: Zong, Yan-Jun, et al.
Publicado: (2023)

Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease
por: Enomoto, Yasunori, et al.
Publicado: (2017)

Clinical Significance of Serum Galectin-9 and Soluble CD155 Levels in Patients with Systemic Sclerosis
por: Chihara, Mami, et al.
Publicado: (2018)

Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1
por: Peluso, Michael J, et al.
Publicado: (2020)

Brentuximab Vedotin in CD30+ Lymphomas
por: Perini, Guilherme Fleury, et al.
Publicado: (2013)

First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers
por: Angevin, Eric, et al.
Publicado: (2017)

Monitoring and characterizing soluble and membrane-bound ectonucleotidases CD73 and CD39
por: Goueli, Said A., et al.
Publicado: (2019)

Characterization of CD30/CD30L(+) Cells in Peripheral Blood and Synovial Fluid of Patients with Rheumatoid Arthritis
por: Barbieri, Alessandro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_db7stq95ctfnm6fbsd94lqshdo